Indirect Research Cost Shortfall
Definition
MRFF provides hundreds of millions to universities, but Research Support Program fails to cover indirect costs, leading to capacity loss in research infrastructure and operations.
Key Findings
- Financial Impact: Substantial increase needed in Research Support Program (est. 10-20% of MRFF grants, or $65-130M based on $650M disbursement)
- Frequency: Per grant cycle
- Root Cause: Poor tracking of indirect costs in grant budgets; manual reporting misses advocacy for increased program funding
Why This Matters
The Pitch: Biotechnology firms in Australia lose millions annually on unfunded indirect research costs. Automated grant reporting ensures full cost recovery.
Affected Stakeholders
Finance Teams, Project Leads, University Admin
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Evidence Sources:
Related Business Risks
Grant Funding Underspend
Delayed R&D Disbursement Losses
TGA CTN/CTA Notification Costs
Biosafety Non-Compliance Fines
HREC and SSA Approval Delays
Embryo Research Licensing Overhead
Request Deep Analysis
🇦🇺 Be first to access this market's intelligence